Concordia Healthcare Corp. T.CXR.R

Boy am I glad I was out! but at $11 and change???

[FullReversal]

I've been buying and selling this this over longer cycles and doing well.   At below $12.... the other shoe can fall here with banksters' downgrades or take over suitors can be tripping over each other for a chance to take this on.

Problem is, if they want to take it private, they can continue to pound away at it at shareholder's expense. I actually hate the sector, drug price gouging isn't what makes me a proud member of the true investor community.  Brand names are under assault from the generics and that's supported by the politicians and public.

That and the Amdipharm Mercury acquisition stinks to high heaven, that's the biggest obstacle I see to me putting my money back on this horse! But from a pure financial perspective, sub $12 looks mighty good.... Anyone have any better picks for the contrarians?

Or maybe I'll just wait this out a bit more....  Let's see if there is any intelligence responses...  Something very, very hard to get from Stockhouse...

[CNInvesting]

Yes there's something a lot better for a contrarian...short the S&P500. It's gonna crash sooner or later. Markets are disconnected from the underlying economy sucks and debt to gdp is at an all-time high. Right now S&P is trading at a 20x p/e. I think it should be trading at max 16x. You're right that there's a reasonnable margin of safety with CXR right now, but not

[FullReversal]

Sorry, I'm a contrarian investor. I know I should probably short and retail investment platforms now have views into your short positions but that's even more ammunition by the street (most of you 24x7 guys) against the little part time investor.  The average guys can't beat the street, it's like trying to win against the House. Shorting is the cancer of the investment

[Marky1]

CN great post! I am a contrarian investor as well..I bought into CXR at..$12.00.... I do see value in the company and have been in touch with IR weekly now.(Adam in IR)..The company has over 50 new products coming online in the next few years....When each one does we should see a gap upwards I would presume...The huge write off they had in Q2 is a one time event and Q3 results should be a lot

[Shortingtozero1]

This post has been removed in accordance with Community Policy

[FullReversal]

Excellent argument and speculation here.  But shorters and take-over guys want this to go to zero (or near zero). And they seem to have a fair amount of ammunition.  If that "CFO working for an auditor thing is true", wow....  I haven't been following the bullboards because it's full of 24x7 idiots but I have this weird attraction to these clown shows. But they

[Shortingtozero1]

This post has been removed in accordance with Community Policy

[Marky1]

Good point shortingtozero! AND tiger he QUIT!

[Mulaman1]

This post has been removed in accordance with Community Policy

[LaticeInExile]

This post has been removed in accordance with Community Policy

[wallop13]

On the surface the company looks like a value play. My main concern is Donnatal. It has yet to prove to the FDA it is effective. 18,400 DESI drugs have proven they are effective. Donnatal is 2 of only 12 that has yet to prove it is effective. Sooner or later the FDA will get tired of waiting for evidence and just proceed. Has anybody asked the company about this?

[select1011]

This post has been removed in accordance with Community Policy